Prime Capital Investment Advisors, LLC
Position in LLY — ELI LILLY & Co
CIK 1731446
OVERLAND PARK, KS
Position in LLY
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$75,746,409
+$15,816,956 QoQ
Shares Held
63,152
-3.1% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
2.07%
of 13F equity value
Holder Rank
#441
of 4,605 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Prime Capital Investment Advisors, LLC holds $167,982,283 across 14 Drug Manufacturers - General names. LLY ranks #1 (45.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
63,152 | $75,746,409 | |
| 2 | ABBV |
AbbVie Inc.
|
128,509 | $32,338,004 | |
| 3 | JNJ |
Johnson & Johnson
|
127,237 | $32,314,380 | |
| 4 | AMGN |
Amgen Inc
|
15,849 | $5,739,239 | |
| 5 | MRK |
Merck & Co., Inc.
|
43,565 | $5,598,102 | |
| 6 | PFE |
Pfizer Inc
|
113,165 | $2,725,013 | |
| 7 | NVO |
Novo Nordisk A S
|
56,457 | $2,706,548 | |
| 8 | NVS |
Novartis AG
|
16,577 | $2,597,947 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $75,746,409 | 63,152 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $59,929,453 | 65,157 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $76,003,526 | 70,722 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $52,630,214 | 68,978 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $50,048,944 | 64,204 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $68,556,311 | 83,007 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $47,009,396 | 60,893 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $57,029,729 | 64,372 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $56,800,825 | 62,737 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $55,106,018 | 70,834 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $45,493,991 | 78,045 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $37,109,774 | 69,089 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $28,247,603 | 60,232 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $10,223,269 | 29,769 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $17,927,257 | 49,003 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $6,884,121 | 21,290 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $4,421,524 | 13,637 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $5,135,759 | 17,934 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $5,011,459 | 18,143 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $2,174,180 | 9,410 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $5,687,276 | 24,779 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $4,257,814 | 22,791 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $1,771,131 | 10,490 | Shares | Sole | 2021-02-03 | |
| 2020-06-30 | $130,851 | 797 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $141,633 | 1,021 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||